Sonora Investment Management Group’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-800
Closed -$240K 310
2024
Q3
$240K Sell
800
-245
-23% -$75K 0.02% 245
2024
Q2
$414K Hold
1,045
0.03% 188
2024
Q1
$414K Sell
1,045
-5
-0.5% -$1.85K 0.03% 188
2023
Q4
$370K Hold
1,050
0.03% 188
2023
Q3
$394K Sell
1,050
-340
-24% -$131K 0.03% 180
2023
Q2
$532K Hold
1,390
0.04% 157
2023
Q1
$482K Hold
1,390
0.04% 160
2022
Q4
$327K Sell
1,390
-800
-37% -$190K 0.03% 197
2022
Q3
$662K Hold
2,190
0.09% 119
2022
Q2
$662K Hold
2,190
0.06% 150
2022
Q1
$899K Hold
2,190
0.1% 114
2021
Q4
$1.03M Buy
+2,190
New +$943K 0.12% 106

Other funds holding WST

Sonora Investment Management Group's WST Position: Q4 2024 in Review

Sonora Investment Management Group sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 800 shares — an estimated $240K sold.

Sonora Investment Management Group first reported a position in WST in Q4 2021 and held it in 12 quarters. The position peaked at $1.03M in Q4 2021. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Sonora Investment Management Group reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Sonora Investment Management Group sold 800 West Pharmaceutical shares in Q4 2024, an estimated $240K.
  • Sonora Investment Management Group first reported a position in West Pharmaceutical in Q4 2021 and held it in 12 quarters.
  • Sonora Investment Management Group's West Pharmaceutical position peaked at $1.03M in Q4 2021.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Sonora Investment Management Group's 13F filing for Q4 2024, filed 23 Jan 2025.